# THEOPHYLLINE
> **ANDA216300** · Abbreviated New Drug Application (Generic) · Sponsor: BIONPHARMA · Approved 2023-04-26
## Drug
- **FDA Application Number:** ANDA216300
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** THEOPHYLLINE
- **Generic name:** THEOPHYLLINE
- **Active ingredients:** THEOPHYLLINE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** BIONPHARMA
- **Manufacturer:** Bionpharma Inc.,
- **First approval:** 2023-04-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216300)
---
*MORVS · CC0 1.0*